Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions

Modern Pathology

Volumn 26, Issue 3, 2013, Pages 385-392

  Sullivan, Lisa M ^a   Folpe, Andrew L ^b   Pawel, Bruce R ^a   Judkins, Alexander R ^c   Biegel, Jaclyn A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

epithelioid sarcoma; malignant rhabdoid tumor; SMARCB1

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPITHELIOID SARCOMA; FEMALE; GENE; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; SMARCB1 GENE;

EID: 84875215214     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.175     Document Type: Article

References (31)

1. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-79.
2. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394:203-206.
3. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004; 28:1485-1491.
4. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004;28:644-650.
5. Jackson EM, Sievert AJ, Gai X, et al. Genomic analysis using high-density single nucleotide polymorphismbased oligonucleotide arrays and multiplex ligationdependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 2009;15:1923-1930.
6. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011;56:7-15.
7. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol 2008;21:647-652.
8. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol 2009;33:542-550.
9. Kreiger PA, Judkins AR, Russo PA, et al. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol 2009;22:142-150.
10. Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol 2007; 31:1813-1824.
11. Kohashi K, Oda Y, Yamamoto H, et al. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol 2010;23:981-990.
12. Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 2009; 52:328-334.
13. Guillou L, Wadden C, Coindre JM, et al. 'Proximaltype' epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol 1997;21:130-146.
14. Chbani L, Guillou L, Terrier P, et al. Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the french sarcoma group. Am J Clin Pathol 2009;131:222-227.
15. Oda Y, Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue: Clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 2006;56:287-295.
16. Lualdi E, Modena P, Debiec-Rychter M, et al. Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer 2004;41:283-290.
17. Feely MG, Fidler ME, Nelson M, et al. Cytogenetic findings in a case of epithelioid sarcoma and a review of the literature. Cancer Genet Cytogenet 2000;119: 155-157.
18. Weiss S, Goldblum R(eds) Enzinger & Weiss's soft tissue tumors; 5th edn., Mosby Elsevier: China; 2008, pp 1191-1203.
19. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 2005;65:4012-4019.
20. Kohashi K, Izumi T, Oda Y, et al. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum Pathol 2009; 40:349-355.
21. Gasparini P, Facchinetti F, Boeri M, et al. Prognostic determinants in epithelioid sarcoma. Eur J Cancer 2011;47:287-295.
22. Flucke U, Slootweg PJ, Mentzel T, et al. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Hum Pathol 2009;40:1361 2; author reply 1362-4.
23. den Dunnen JT, White SJ. MLPA and MAPH: sensitive detection of deletions and duplications. Curr Protoc Hum Genet 2006; Chapter 7:Unit 7.14.
24. Jalali GR, Vorstman JA, Errami A, et al. Detailed analysis of 22q11.2 with a high density MLPA probe set. Hum Mutat 2008;29:433-440.
25. de Visscher SA, van Ginkel RJ, Wobbes T, et al. Epithelioid sarcoma: still an only surgically curable disease. Cancer 2006;107:606-612.
26. Chase DR, Enzinger FM. Epithelioid sarcoma. diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 1985;9:241-263.
27. Casanova M, Ferrari A, Collini P, et al. Italian Soft Tissue Sarcoma Committee. Epithelioid sarcoma in children and adolescents: a report from the italian soft tissue sarcoma committee. Cancer 2006;106: 708-717.
28. Bourdeaut F, Lequin D, Brugieres L, et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 2011;17:31-38.
29. Murray PM. Soft tissue sarcoma of the upper extremity. Hand Clin 2004;20:325-333; vii.
30. Whitworth PW, Pollock RE, Mansfield PF, et al. Extremity epithelioid sarcoma. Amputation vs local resection. Arch Surg 1991;126:1485-1489.
31. Callister MD, Ballo MT, Pisters PW, et al. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2001;51: 384-391.